DK288877A - Fremgangsmade til bekempelse af virusinfektioner - Google Patents

Fremgangsmade til bekempelse af virusinfektioner

Info

Publication number
DK288877A
DK288877A DK288877A DK288877A DK288877A DK 288877 A DK288877 A DK 288877A DK 288877 A DK288877 A DK 288877A DK 288877 A DK288877 A DK 288877A DK 288877 A DK288877 A DK 288877A
Authority
DK
Denmark
Prior art keywords
methods
virus infections
fighting
fighting virus
infections
Prior art date
Application number
DK288877A
Other languages
Danish (da)
English (en)
Inventor
B F H Eriksson
A J E Helgstrand
A Misiorny
G B Stening
S A A Stridh
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK288877(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of DK288877A publication Critical patent/DK288877A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK288877A 1976-07-01 1977-06-29 Fremgangsmade til bekempelse af virusinfektioner DK288877A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Publications (1)

Publication Number Publication Date
DK288877A true DK288877A (da) 1978-01-02

Family

ID=20328354

Family Applications (1)

Application Number Title Priority Date Filing Date
DK288877A DK288877A (da) 1976-07-01 1977-06-29 Fremgangsmade til bekempelse af virusinfektioner

Country Status (22)

Country Link
US (4) US4215113A (es)
JP (1) JPS536428A (es)
AT (1) AT369014B (es)
AU (1) AU510809B2 (es)
BE (1) BE856355A (es)
BG (1) BG60834B2 (es)
CA (1) CA1077848A (es)
CH (1) CH641471A5 (es)
DE (1) DE2728685C2 (es)
DK (1) DK288877A (es)
FI (1) FI772030A (es)
FR (1) FR2356424A1 (es)
GB (1) GB1585615A (es)
HK (1) HK28984A (es)
IE (1) IE45753B1 (es)
LU (2) LU77666A1 (es)
MX (1) MX9203635A (es)
MY (1) MY8500125A (es)
NL (2) NL180068C (es)
NO (1) NO772299L (es)
SE (1) SE7607496L (es)
SG (1) SG80383G (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
DK564378A (da) * 1977-12-22 1979-06-23 Astra Laekemedel Ab Fremgangsmaade til fremstilling af amidderivater til bekaempelse af virusinfektioner
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
MC1585A1 (fr) * 1982-02-12 1985-02-22 Ens Bio Logicals Inc Procede de fabrication de compositions antivirales
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
EP0243352A1 (en) * 1985-10-21 1987-11-04 SERGIO, William Method for reducing the risk or probability of infection from the aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
EP0831842A4 (en) * 1995-06-06 1998-08-19 Univ Southern California METHOD AND MEANS FOR INHIBITING PROPAGATION OF THE CYTOMEGALOVIRUS
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
US20060166941A1 (en) * 2003-03-14 2006-07-27 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
WO2006119174A1 (en) * 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US9006219B2 (en) * 2008-03-12 2015-04-14 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (en) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Transmucosal dosage forms of foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Also Published As

Publication number Publication date
FR2356424A1 (fr) 1978-01-27
BE856355A (fr) 1978-01-02
ATA465477A (de) 1982-04-15
DE2728685A1 (de) 1978-01-12
CH641471A5 (de) 1984-02-29
FI772030A (es) 1978-01-02
NL180068C (nl) 1987-01-02
US4665062A (en) 1987-05-12
BG60834B2 (bg) 1996-04-30
US4339445A (en) 1982-07-13
MX9203635A (es) 1992-09-01
LU77666A1 (es) 1977-10-07
JPS536428A (en) 1978-01-20
LU88310I2 (fr) 1994-05-04
JPS562046B2 (es) 1981-01-17
NL180068B (nl) 1986-08-01
AU510809B2 (en) 1980-07-17
CA1077848A (en) 1980-05-20
NL930053I2 (nl) 1994-01-03
IE45753B1 (en) 1982-11-17
MY8500125A (en) 1985-12-31
DE2728685C2 (de) 1982-09-16
US4771041A (en) 1988-09-13
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
SE7607496L (sv) 1978-01-02
NL930053I1 (nl) 1993-09-01
FR2356424B1 (es) 1980-04-18
AT369014B (de) 1982-11-25
NL7707235A (nl) 1978-01-03
NO772299L (no) 1978-04-25
US4215113A (en) 1980-07-29
SG80383G (en) 1984-08-03
GB1585615A (en) 1981-03-11
AU2650577A (en) 1979-01-04

Similar Documents

Publication Publication Date Title
DK288877A (da) Fremgangsmade til bekempelse af virusinfektioner
DK499477A (da) Anvendelse af ergotpeptidalkaloid-praeparat
DK30277A (da) Fremgangsmade til fremstilling af substituerede phenylamidiner
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK542878A (da) Fremgangsmaade til propagering af virus
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK587077A (da) Fremgangsmaade til fremstilling af estere
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK233477A (da) Fremgangsmade til fremstilling af antiotiske midler
DK88777A (da) Fremgangsmade til fremstilling af substituerede azapuriner
DK318876A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK517176A (da) Fremstilling af ethylchlorthioformiat
DK271377A (da) Fremgangsmade til fremstilling af substituerede arylacetamidocephalosporiner
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK73277A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK549577A (da) Fremgangsmaade til fremsitlling af oelurt
DK582177A (da) Fremgangsmaade til fremstilling af halogenacylamider
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK564977A (da) Fremgangsmaade til fremstilling af antirhinovirusmidler
DK97177A (da) Fremgangsmade til fremstilling af cyanoalkylureidocephalosporiner
DK106677A (da) Fremgangsmade til fremstilling af 3-nethylencephalosporiner

Legal Events

Date Code Title Description
ARF Application refused